Canyon Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$36.8M |
| 2 |
Tenet Healthcare
THC
|
+$20.9M |
| 3 |
SJR
Shaw Communications Inc.
SJR
|
+$15.9M |
| 4 |
Rush Street Interactive
RSI
|
+$4.26M |
| 5 |
ACOR
Acorda Therapeutics
ACOR
|
+$484K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$65.1M |
| 2 |
Bausch Health
BHC
|
+$59.4M |
| 3 |
Encompass Health
EHC
|
+$52.7M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$50.1M |
| 5 |
T-Mobile US
TMUS
|
+$48.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 16.08% |
| 2 | Technology | 15.91% |
| 3 | Real Estate | 15.68% |
| 4 | Consumer Discretionary | 15.26% |
| 5 | Materials | 11.93% |
Similar funds
Canyon Capital Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Canyon Capital Advisors held 82 positions worth $1.26B, down 53% from $2.7B the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Canyon Capital Advisors withdrew a net $540M in Q2 2022, closing 20 positions and reducing 7 holdings. Its most notable exit was VMware, Inc, an estimated $65.1M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 16% of assets, up from 10% a quarter earlier, followed by Technology and Real Estate.
Against the trend, Canyon Capital Advisors added an estimated $36.8M to Change Healthcare Inc. Common Stock.
- Canyon Capital Advisors added most to Change Healthcare Inc. Common Stock in Q2 2022, an estimated $36.8M increase.
- Canyon Capital Advisors's biggest Q2 2022 reduction was Encompass Health, cutting an estimated $52.7M.
- Canyon Capital Advisors fully exited VMware, Inc in Q2 2022, selling an estimated $65.1M.
- Canyon Capital Advisors's ten largest holdings make up 83% of its $1.26B portfolio in Q2 2022.
- Canyon Capital Advisors opened 0 new positions and closed 20 in Q2 2022.
- Canyon Capital Advisors's portfolio value fell 53% quarter-over-quarter to $1.26B.
Based on Canyon Capital Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.